Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Edwin Asturias

Concepts (460)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Guatemala
53
2025
326
4.200
 Why?
Microcephaly
5
2024
97
2.770
 Why?
Zika Virus Infection
6
2024
165
2.700
 Why?
Influenza, Human
9
2025
618
2.520
 Why?
Vaccines
7
2024
405
2.430
 Why?
Rural Population
17
2025
561
2.420
 Why?
Poliovirus Vaccine, Inactivated
6
2018
28
2.160
 Why?
Vaccination
16
2025
1377
2.020
 Why?
Poliomyelitis
8
2018
37
1.930
 Why?
Poliovirus Vaccine, Oral
7
2018
25
1.790
 Why?
Zika Virus
5
2024
128
1.740
 Why?
Infant
44
2025
9395
1.680
 Why?
Dengue
6
2024
80
1.580
 Why?
Viral Vaccines
4
2025
98
1.410
 Why?
Child Development
4
2025
464
1.360
 Why?
Virus Shedding
9
2024
48
1.280
 Why?
Streptococcus pneumoniae
5
2025
169
1.260
 Why?
Pneumonia, Pneumococcal
3
2025
48
1.190
 Why?
Community-Acquired Infections
3
2025
169
1.160
 Why?
Caliciviridae Infections
2
2018
19
1.120
 Why?
Norovirus
2
2018
26
1.110
 Why?
Poliovirus
6
2018
85
1.080
 Why?
Haemophilus Vaccines
5
2016
30
1.050
 Why?
Gastroenteritis
2
2017
68
1.040
 Why?
Child, Preschool
30
2025
10997
1.030
 Why?
Dengue Virus
6
2024
52
1.010
 Why?
Reminder Systems
2
2019
168
0.990
 Why?
Text Messaging
2
2019
156
0.960
 Why?
Growth Disorders
2
2023
86
0.950
 Why?
Health Knowledge, Attitudes, Practice
5
2023
1322
0.920
 Why?
Hepatitis B Vaccines
4
2016
45
0.920
 Why?
Antigens, Bacterial
1
2025
129
0.900
 Why?
Fever
2
2017
306
0.900
 Why?
Humans
99
2025
136803
0.860
 Why?
Immunization Schedule
5
2017
195
0.860
 Why?
Streptococcal Vaccines
1
2023
6
0.850
 Why?
Immunization
4
2023
411
0.820
 Why?
Meningitis, Meningococcal
1
2022
6
0.800
 Why?
Neisseria meningitidis
1
2022
23
0.790
 Why?
Cell Phone
3
2019
75
0.790
 Why?
Meningococcal Infections
1
2022
25
0.790
 Why?
Child
28
2025
21819
0.770
 Why?
Meningococcal Vaccines
1
2022
55
0.760
 Why?
Neurodevelopmental Disorders
1
2024
176
0.750
 Why?
Family Characteristics
5
2025
189
0.730
 Why?
Prospective Studies
17
2025
7573
0.730
 Why?
Streptococcal Infections
1
2023
151
0.720
 Why?
Female
59
2025
72816
0.690
 Why?
Serogroup
5
2025
44
0.690
 Why?
Infant, Newborn
16
2025
6032
0.670
 Why?
Antibodies, Neutralizing
4
2017
285
0.670
 Why?
Virus Diseases
1
2022
213
0.670
 Why?
Pregnancy Complications, Infectious
2
2022
390
0.660
 Why?
Endpoint Determination
1
2020
77
0.660
 Why?
Rural Health Services
2
2019
128
0.650
 Why?
Product Surveillance, Postmarketing
2
2025
63
0.650
 Why?
Diarrhea
5
2023
183
0.640
 Why?
Adverse Drug Reaction Reporting Systems
2
2025
77
0.630
 Why?
Immunity, Humoral
3
2017
116
0.630
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
3
2016
25
0.630
 Why?
Influenza Vaccines
3
2021
537
0.620
 Why?
Contraception
4
2022
159
0.610
 Why?
Adolescent Health
1
2019
39
0.600
 Why?
Immunity, Mucosal
2
2016
97
0.590
 Why?
Arbovirus Infections
1
2018
21
0.590
 Why?
Community Health Services
2
2019
227
0.580
 Why?
Sentinel Surveillance
2
2017
48
0.580
 Why?
Patient Acceptance of Health Care
3
2020
805
0.580
 Why?
Haemophilus influenzae type b
2
2014
12
0.570
 Why?
Male
48
2025
67330
0.570
 Why?
Carrier State
3
2014
67
0.560
 Why?
Urban Health Services
1
2017
63
0.540
 Why?
Immunogenicity, Vaccine
1
2017
30
0.540
 Why?
Multiplex Polymerase Chain Reaction
3
2025
54
0.520
 Why?
Consumer Product Safety
1
2016
33
0.510
 Why?
Community Health Planning
1
2016
43
0.500
 Why?
Neonatal Screening
1
2017
169
0.500
 Why?
Public-Private Sector Partnerships
1
2016
43
0.500
 Why?
Physician Assistants
1
2017
92
0.490
 Why?
Family Planning Services
3
2022
92
0.480
 Why?
Anemia, Hemolytic
1
2015
20
0.480
 Why?
Population Health
1
2016
47
0.480
 Why?
Parents
3
2023
1340
0.480
 Why?
Schools
1
2019
461
0.470
 Why?
Population Surveillance
2
2025
474
0.470
 Why?
Latin America
5
2018
93
0.470
 Why?
Post-Exposure Prophylaxis
1
2014
9
0.460
 Why?
Castleman Disease
1
2014
13
0.460
 Why?
Mobile Applications
1
2017
182
0.450
 Why?
Herpes Zoster
2
2015
316
0.450
 Why?
Exanthema
1
2015
78
0.450
 Why?
Advisory Committees
1
2016
219
0.450
 Why?
Sexual Behavior
1
2019
484
0.450
 Why?
Needs Assessment
2
2016
372
0.440
 Why?
Haemophilus Infections
1
2014
42
0.440
 Why?
Pregnancy
13
2024
6729
0.440
 Why?
Adolescent
23
2025
21385
0.440
 Why?
Brain Diseases
1
2015
141
0.430
 Why?
Bacterial Capsules
2
2014
30
0.420
 Why?
Caregivers
1
2021
870
0.420
 Why?
Calcitonin
1
2013
27
0.420
 Why?
Adolescent Behavior
1
2019
529
0.420
 Why?
Receptors, Interleukin-6
1
2013
43
0.420
 Why?
Health Behavior
1
2019
756
0.410
 Why?
Global Health
1
2016
385
0.400
 Why?
Protein Precursors
1
2013
132
0.400
 Why?
Antibodies, Bacterial
2
2014
146
0.400
 Why?
Bacterial Infections
2
2013
250
0.390
 Why?
Young Adult
17
2025
13129
0.380
 Why?
Drug-Related Side Effects and Adverse Reactions
3
2025
250
0.380
 Why?
Hospitalization
7
2022
2184
0.380
 Why?
Feces
8
2018
481
0.370
 Why?
Adult
30
2025
37643
0.370
 Why?
Intestines
4
2018
357
0.370
 Why?
Chikungunya Fever
2
2025
79
0.360
 Why?
Antibodies, Monoclonal, Humanized
2
2014
801
0.360
 Why?
Diet
1
2019
1274
0.350
 Why?
Intestinal Mucosa
1
2016
621
0.350
 Why?
Antigens, Viral
2
2024
181
0.340
 Why?
Contraceptive Agents
2
2021
66
0.340
 Why?
Pleural Effusion
2
2024
54
0.330
 Why?
Saccharum
3
2020
77
0.320
 Why?
Hepatitis B Antibodies
1
2009
11
0.310
 Why?
Surveys and Questionnaires
5
2021
5744
0.310
 Why?
Nasopharynx
2
2025
76
0.300
 Why?
Dengue Vaccines
2
2018
10
0.290
 Why?
Immunosuppressive Agents
1
2013
889
0.290
 Why?
Agriculture
2
2020
101
0.290
 Why?
Delivery, Obstetric
2
2019
145
0.290
 Why?
Antibodies, Viral
7
2022
624
0.290
 Why?
Malnutrition
1
2009
82
0.280
 Why?
Urban Population
3
2019
476
0.280
 Why?
World Health Organization
3
2017
123
0.280
 Why?
Appointments and Schedules
2
2019
89
0.270
 Why?
Primary Health Care
1
2017
1722
0.260
 Why?
RNA, Viral
2
2021
654
0.260
 Why?
Seroconversion
2
2017
46
0.260
 Why?
Acute Disease
3
2019
1007
0.260
 Why?
Cohort Studies
6
2025
5704
0.250
 Why?
Cross-Sectional Studies
5
2023
5424
0.250
 Why?
Anti-Bacterial Agents
4
2025
1798
0.250
 Why?
Immunization Programs
3
2024
213
0.240
 Why?
Blood Culture
1
2025
23
0.240
 Why?
Glomerular Filtration Rate
2
2020
745
0.230
 Why?
Viruses
2
2023
112
0.230
 Why?
Viral Load
2
2024
464
0.230
 Why?
Anthropometry
2
2022
213
0.230
 Why?
Vaccines, Conjugate
2
2022
65
0.220
 Why?
Head
1
2025
105
0.220
 Why?
Chikungunya virus
1
2025
80
0.220
 Why?
Meningitis, Haemophilus
1
2003
6
0.220
 Why?
Bacteremia
2
2025
212
0.220
 Why?
Postpartum Period
3
2022
338
0.210
 Why?
Culex
1
2023
16
0.210
 Why?
Ritonavir
1
2024
74
0.210
 Why?
Respiratory Syncytial Virus Infections
1
2025
127
0.210
 Why?
Saliva
1
2025
242
0.210
 Why?
Streptococcus pyogenes
1
2023
45
0.200
 Why?
Antimicrobial Stewardship
1
2025
117
0.200
 Why?
Aedes
1
2023
65
0.200
 Why?
Postnatal Care
2
2021
70
0.200
 Why?
Anti-Infective Agents
2
2020
254
0.200
 Why?
Psychometrics
3
2021
720
0.200
 Why?
Incidence
4
2022
2797
0.200
 Why?
Vomiting
1
2023
130
0.200
 Why?
Propensity Score
1
2024
289
0.200
 Why?
Travel
3
2015
130
0.190
 Why?
Seroepidemiologic Studies
2
2022
165
0.190
 Why?
Seasons
2
2025
544
0.190
 Why?
Vital Signs
1
2022
43
0.190
 Why?
Cough
1
2023
122
0.190
 Why?
Vaccines, Attenuated
2
2025
131
0.190
 Why?
Regression Analysis
2
2022
1022
0.190
 Why?
Quality Improvement
5
2022
1163
0.190
 Why?
Biomarkers
1
2013
4145
0.190
 Why?
Meningitis, Bacterial
2
2015
47
0.190
 Why?
Herpesvirus 3, Human
2
2015
332
0.190
 Why?
Risk Factors
10
2025
10332
0.180
 Why?
Polymerase Chain Reaction
1
2024
1059
0.180
 Why?
Escherichia coli Vaccines
2
2013
4
0.180
 Why?
Drug Therapy, Combination
3
2016
1062
0.180
 Why?
Vaccines, Combined
3
2024
48
0.180
 Why?
Health Services Accessibility
2
2020
978
0.180
 Why?
Cesarean Section
2
2019
183
0.180
 Why?
Health Promotion
2
2019
734
0.180
 Why?
Attitude
1
2023
259
0.180
 Why?
Midwifery
1
2022
52
0.180
 Why?
Malaria Vaccines
1
2020
8
0.180
 Why?
Influenza A Virus, H3N2 Subtype
1
2021
47
0.170
 Why?
Respiratory Tract Infections
1
2025
394
0.170
 Why?
Outpatients
1
2024
393
0.170
 Why?
Yellow fever virus
1
2020
4
0.170
 Why?
Birth Intervals
1
2020
22
0.170
 Why?
Public Health
3
2025
579
0.170
 Why?
Immunologic Deficiency Syndromes
2
2015
69
0.170
 Why?
Reproducibility of Results
4
2021
3265
0.170
 Why?
Yellow Fever
1
2020
8
0.170
 Why?
Maternal Health Services
1
2022
97
0.170
 Why?
Molecular Diagnostic Techniques
1
2021
105
0.160
 Why?
Absenteeism
1
2020
48
0.160
 Why?
Cesarean Section, Repeat
1
2019
11
0.160
 Why?
Intensive Care, Neonatal
1
2020
40
0.160
 Why?
Vaccination Refusal
1
2020
70
0.160
 Why?
Emergency Service, Hospital
2
2022
2048
0.160
 Why?
Vaginal Birth after Cesarean
1
2019
25
0.160
 Why?
Agricultural Workers' Diseases
1
2020
31
0.160
 Why?
Drug Discovery
1
2020
141
0.160
 Why?
Language Tests
1
2019
23
0.160
 Why?
Contraception Behavior
1
2020
102
0.160
 Why?
Maternal Age
1
2019
129
0.150
 Why?
Language Development Disorders
1
2019
41
0.150
 Why?
Real-Time Polymerase Chain Reaction
1
2020
346
0.150
 Why?
Motor Skills
1
2020
97
0.150
 Why?
Arboviruses
1
2018
16
0.150
 Why?
Clinical Trials as Topic
1
2023
1044
0.150
 Why?
Thinness
1
2019
91
0.150
 Why?
Puerto Rico
1
2018
53
0.150
 Why?
Entamoeba histolytica
1
2018
7
0.150
 Why?
Pregnancy in Adolescence
1
2019
81
0.140
 Why?
Farmers
1
2019
64
0.140
 Why?
Heat Stress Disorders
1
2019
75
0.140
 Why?
Socioeconomic Factors
2
2025
1282
0.140
 Why?
Treatment Refusal
1
2018
89
0.140
 Why?
Vulnerable Populations
1
2019
162
0.140
 Why?
Mothers
3
2022
752
0.140
 Why?
Child Health
1
2019
154
0.130
 Why?
Sensitivity and Specificity
4
2025
1936
0.130
 Why?
Educational Status
1
2019
470
0.130
 Why?
Occupational Health
2
2018
200
0.130
 Why?
Neoplasms
2
2016
2643
0.130
 Why?
Intensive Care Units, Neonatal
1
2020
253
0.130
 Why?
Diagnostic Tests, Routine
1
2018
110
0.130
 Why?
Poliovirus Vaccines
1
2016
6
0.130
 Why?
Middle Aged
11
2025
33239
0.130
 Why?
Colorado
3
2024
4515
0.130
 Why?
Health Surveys
1
2019
513
0.130
 Why?
Pneumococcal Infections
2
2016
115
0.130
 Why?
Central Nervous System Viral Diseases
1
2018
79
0.130
 Why?
HIV Infections
2
2014
2828
0.130
 Why?
Child Behavior
1
2019
246
0.130
 Why?
Panama
1
2016
13
0.130
 Why?
Myelitis
1
2018
107
0.130
 Why?
Colombia
1
2016
41
0.130
 Why?
Dominican Republic
1
2016
25
0.130
 Why?
Neuromuscular Diseases
1
2018
122
0.130
 Why?
Databases, Factual
3
2019
1351
0.130
 Why?
Community Health Nursing
1
2016
60
0.120
 Why?
Peru
1
2016
58
0.120
 Why?
Measles-Mumps-Rubella Vaccine
1
2016
42
0.120
 Why?
Risk-Taking
1
2019
347
0.120
 Why?
Host-Pathogen Interactions
1
2019
363
0.120
 Why?
Sanitation
1
2016
55
0.120
 Why?
Anemia, Hemolytic, Autoimmune
1
2015
14
0.120
 Why?
Learning
1
2020
407
0.120
 Why?
Rotavirus Vaccines
1
2016
46
0.120
 Why?
Water Supply
1
2016
78
0.120
 Why?
Health Services Needs and Demand
1
2017
272
0.120
 Why?
Chickenpox
1
2016
83
0.120
 Why?
Single-Blind Method
1
2016
282
0.120
 Why?
Analysis of Variance
1
2018
1316
0.120
 Why?
Typhoid Fever
1
2015
10
0.120
 Why?
Occupational Exposure
1
2019
338
0.120
 Why?
Patient Preference
1
2017
190
0.120
 Why?
Health Information Systems
1
2015
17
0.120
 Why?
Enterovirus Infections
1
2018
177
0.120
 Why?
Community Participation
1
2016
130
0.120
 Why?
Data Collection
1
2018
668
0.120
 Why?
Aged, 80 and over
2
2025
7593
0.110
 Why?
Education, Nursing
1
2016
93
0.110
 Why?
Antibody Affinity
1
2014
60
0.110
 Why?
Disease Outbreaks
1
2018
386
0.110
 Why?
Fatal Outcome
1
2015
303
0.110
 Why?
Malaria
1
2015
63
0.110
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2014
86
0.110
 Why?
Overweight
1
2019
557
0.110
 Why?
Biomedical Research
1
2020
688
0.110
 Why?
Vincristine
1
2014
116
0.110
 Why?
Cyclophosphamide
1
2014
247
0.110
 Why?
History, 21st Century
1
2014
212
0.110
 Why?
Severity of Illness Index
2
2020
2822
0.110
 Why?
Mucocutaneous Lymph Node Syndrome
1
2014
91
0.110
 Why?
Enterotoxins
1
2013
87
0.110
 Why?
Rituximab
1
2014
176
0.110
 Why?
Prednisone
1
2014
239
0.100
 Why?
Calcitonin Gene-Related Peptide
1
2013
38
0.100
 Why?
Universities
1
2016
433
0.100
 Why?
Renal Insufficiency, Chronic
1
2020
612
0.100
 Why?
History, 20th Century
1
2014
324
0.100
 Why?
Students
1
2019
624
0.100
 Why?
Case-Control Studies
1
2021
3540
0.100
 Why?
Bacterial Toxins
1
2013
105
0.100
 Why?
Causality
1
2013
126
0.100
 Why?
Education, Medical
1
2016
260
0.100
 Why?
Communicable Diseases
1
2015
159
0.100
 Why?
Health Policy
1
2016
385
0.100
 Why?
United States
7
2025
14691
0.100
 Why?
Doxorubicin
1
2014
362
0.100
 Why?
Delivery of Health Care
1
2019
935
0.100
 Why?
Lymphocytes
1
2014
393
0.100
 Why?
Practice Guidelines as Topic
1
2020
1572
0.100
 Why?
Gene Expression Profiling
1
2019
1772
0.090
 Why?
Escherichia coli Proteins
1
2013
194
0.090
 Why?
Lymph Nodes
1
2014
492
0.090
 Why?
Aged
7
2025
23808
0.090
 Why?
Program Evaluation
1
2016
889
0.090
 Why?
Acute Kidney Injury
1
2019
809
0.090
 Why?
Hypertension
1
2020
1285
0.090
 Why?
Kidney
1
2018
1467
0.080
 Why?
Interleukin-6
1
2014
778
0.080
 Why?
Decision Support Systems, Clinical
1
2013
223
0.080
 Why?
Clinical Competence
1
2017
1094
0.080
 Why?
Influenza A Virus, H1N1 Subtype
1
2011
149
0.080
 Why?
Immunization, Secondary
1
2010
89
0.080
 Why?
Escherichia coli
1
2013
807
0.080
 Why?
Physicians
1
2017
907
0.070
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2007
42
0.070
 Why?
Creatinine
2
2020
499
0.070
 Why?
Penicillins
1
2007
58
0.070
 Why?
Drug Resistance, Multiple, Bacterial
1
2007
78
0.070
 Why?
Time Factors
4
2025
6809
0.070
 Why?
Prevalence
2
2025
2710
0.060
 Why?
Contact Tracing
1
2025
26
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
1684
0.060
 Why?
Cities
2
2016
132
0.060
 Why?
Influenza B virus
1
2025
44
0.060
 Why?
Basic Reproduction Number
1
2025
5
0.060
 Why?
Drug Administration Schedule
1
2007
785
0.060
 Why?
Neuropsychological Tests
2
2020
1022
0.060
 Why?
Mexico
3
2013
225
0.060
 Why?
Respiratory Syncytial Virus, Human
1
2025
74
0.060
 Why?
Sepsis
2
2003
614
0.060
 Why?
Influenza A virus
1
2025
110
0.060
 Why?
Tomography, X-Ray Computed
1
2014
2668
0.050
 Why?
Mosquito Vectors
1
2023
30
0.050
 Why?
Policy Making
1
2024
98
0.050
 Why?
Treatment Outcome
4
2020
10748
0.050
 Why?
Haemophilus influenzae
1
2003
63
0.050
 Why?
China
1
2024
216
0.050
 Why?
Chickens
1
2023
191
0.050
 Why?
Antiviral Agents
2
2024
739
0.050
 Why?
Developing Countries
2
2016
306
0.050
 Why?
Bayes Theorem
1
2025
404
0.050
 Why?
Randomized Controlled Trials as Topic
2
2019
1462
0.050
 Why?
Cross Reactions
1
2022
133
0.050
 Why?
Pandemics
1
2011
1616
0.050
 Why?
Longitudinal Studies
2
2020
2829
0.050
 Why?
Mammals
1
2023
283
0.050
 Why?
Methicillin-Resistant Staphylococcus aureus
1
2024
234
0.050
 Why?
Administration, Cutaneous
2
2013
128
0.040
 Why?
Hospitals
2
2016
684
0.040
 Why?
Paraguay
1
2020
3
0.040
 Why?
Sri Lanka
1
2020
7
0.040
 Why?
Endemic Diseases
1
2020
32
0.040
 Why?
Reagent Kits, Diagnostic
1
2020
42
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
1
2022
851
0.040
 Why?
Translations
1
2020
17
0.040
 Why?
Home Health Nursing
1
2019
12
0.040
 Why?
Hospitals, Pediatric
2
2015
505
0.040
 Why?
Specific Gravity
1
2019
11
0.040
 Why?
Child Language
1
2019
19
0.040
 Why?
Parity
1
2019
125
0.040
 Why?
Prenatal Care
1
2022
288
0.040
 Why?
Translating
1
2019
43
0.040
 Why?
Rural Health
1
2019
79
0.040
 Why?
Electrolytes
1
2019
58
0.040
 Why?
Dehydration
1
2019
51
0.040
 Why?
Parasites
1
2019
50
0.040
 Why?
Reproductive Health
1
2019
90
0.040
 Why?
Culturally Competent Care
1
2019
61
0.040
 Why?
Work Capacity Evaluation
1
2018
11
0.040
 Why?
Infectious Disease Transmission, Vertical
1
2020
182
0.040
 Why?
Bacteria
2
2019
854
0.040
 Why?
House Calls
1
2019
129
0.040
 Why?
Feasibility Studies
1
2022
951
0.040
 Why?
Coinfection
1
2019
137
0.040
 Why?
Chi-Square Distribution
1
2019
530
0.040
 Why?
Education, Medical, Continuing
1
2019
127
0.040
 Why?
Adjuvants, Immunologic
1
2019
226
0.040
 Why?
Licensure
1
2017
13
0.040
 Why?
Retrospective Studies
4
2020
15510
0.030
 Why?
Pregnancy Outcome
1
2020
412
0.030
 Why?
Chromatography, Affinity
1
2017
88
0.030
 Why?
Epitope Mapping
1
2017
62
0.030
 Why?
Choice Behavior
1
2019
170
0.030
 Why?
Francisella
1
1997
2
0.030
 Why?
Paralysis
1
2018
70
0.030
 Why?
Parenteral Nutrition
1
1998
107
0.030
 Why?
Counseling
1
2020
388
0.030
 Why?
Granulomatous Disease, Chronic
1
1997
55
0.030
 Why?
Gastrointestinal Tract
1
2019
195
0.030
 Why?
Sequence Alignment
1
2017
342
0.030
 Why?
Gram-Negative Bacterial Infections
1
1997
46
0.030
 Why?
Women's Health
1
2019
369
0.030
 Why?
Double-Blind Method
2
2013
1982
0.030
 Why?
Enterovirus D, Human
1
2018
85
0.030
 Why?
Acyclovir
1
2016
101
0.030
 Why?
ROC Curve
1
2017
545
0.030
 Why?
Chile
1
2015
24
0.030
 Why?
Cholestasis
1
1998
232
0.030
 Why?
IgG Deficiency
2
2006
7
0.030
 Why?
IgA Deficiency
2
2006
6
0.030
 Why?
Age Distribution
1
2016
390
0.030
 Why?
Sex Distribution
1
2016
374
0.030
 Why?
Infusions, Intravenous
1
2016
412
0.030
 Why?
Residence Characteristics
1
2018
350
0.030
 Why?
Spleen
1
1997
514
0.030
 Why?
Pneumococcal Vaccines
1
2016
142
0.030
 Why?
Healthy Volunteers
1
2015
199
0.030
 Why?
Computational Biology
1
2019
643
0.030
 Why?
Pedigree
1
2015
514
0.030
 Why?
Blood Pressure
1
2021
1774
0.030
 Why?
Maternal-Fetal Exchange
1
2014
165
0.030
 Why?
Amino Acid Sequence
1
2017
2138
0.030
 Why?
Transcriptome
1
2019
969
0.020
 Why?
Europe
1
2013
413
0.020
 Why?
Checklist
1
2013
93
0.020
 Why?
Survival Analysis
1
2015
1321
0.020
 Why?
High-Throughput Nucleotide Sequencing
1
2015
535
0.020
 Why?
Adrenal Cortex Hormones
1
2015
556
0.020
 Why?
Survival Rate
1
2016
1964
0.020
 Why?
Lymphocyte Activation
1
2015
1150
0.020
 Why?
Oncology Service, Hospital
1
2011
16
0.020
 Why?
Oseltamivir
1
2011
12
0.020
 Why?
Comorbidity
1
2016
1614
0.020
 Why?
Nuclear Proteins
1
2015
712
0.020
 Why?
Smoking
1
2018
1620
0.020
 Why?
Antibodies, Monoclonal
1
2017
1430
0.020
 Why?
Drug Delivery Systems
1
2013
362
0.020
 Why?
El Salvador
1
2010
6
0.020
 Why?
Body Mass Index
1
2018
2375
0.020
 Why?
Animals
2
2023
36850
0.020
 Why?
Latex Fixation Tests
1
2008
3
0.020
 Why?
Brain Damage, Chronic
1
2008
18
0.020
 Why?
Leukocytosis
1
2008
30
0.020
 Why?
Coma
1
2008
32
0.020
 Why?
Bacteriological Techniques
1
2008
73
0.020
 Why?
Cerebrospinal Fluid
1
2008
92
0.020
 Why?
DNA-Binding Proteins
1
2015
1501
0.020
 Why?
Cells, Cultured
1
2015
4192
0.020
 Why?
Child Day Care Centers
1
2007
35
0.020
 Why?
Shock
1
2008
95
0.020
 Why?
Follow-Up Studies
1
2016
5106
0.020
 Why?
Risk Assessment
1
2016
3434
0.020
 Why?
Ethiopia
1
2006
41
0.020
 Why?
Postoperative Complications
1
1998
2639
0.020
 Why?
Microbial Sensitivity Tests
1
2007
357
0.020
 Why?
Pakistan
1
2006
76
0.020
 Why?
Algorithms
1
2013
1690
0.020
 Why?
Antineoplastic Agents
1
2016
2123
0.010
 Why?
Agammaglobulinemia
1
2004
34
0.010
 Why?
Common Variable Immunodeficiency
1
2004
29
0.010
 Why?
Brazil
1
2004
167
0.010
 Why?
Ambulatory Care
1
2007
539
0.010
 Why?
Confidence Intervals
1
2004
328
0.010
 Why?
United Kingdom
1
2004
310
0.010
 Why?
Short Bowel Syndrome
1
1998
26
0.010
 Why?
Bilirubin
1
1998
97
0.010
 Why?
Liver Failure
1
1998
94
0.010
 Why?
Water Microbiology
1
1997
85
0.010
 Why?
Abscess
1
1997
74
0.010
 Why?
Asturias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (460) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)